Systemic Pharmacokinetics of BOL-303224-A After Single and Multiple Instillations of BOL-303224-A in Subjects With Suspected Bacterial Conjunctivitis.
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2013
At a glance
- Drugs Besifloxacin (Primary)
- Indications Bacterial infections; Conjunctivitis
- Focus Pharmacokinetics
- Sponsors Bausch & Lomb
- 30 Jun 2009 Actual patient number (24) added as reported by ClinicalTrials.gov.
- 13 May 2008 Status changed from recruiting to completed on clinicaltrials.gov
- 13 Dec 2006 New trial record.